CrossrefInfokarte
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
Breast Cancer Research · 2012
DOI: 10.1186/bcr3165 ↗Abstract
Kein Abstract verfügbar.
EUVIMED